Skip to content

Clinical trials

Phase 3 Anemia trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 3 Country / region: Czechia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20043
20061
20074
20092
20101
20131
20145
20163
20171
20191
20202
20213
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting7
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
Amgen3
Celgene3
Akebia Therapeutics2
Astellas Pharma Europe B.V.2
AstraZeneca2
Bristol-Myers Squibb2
CTI BioPharma2
GlaxoSmithKline2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia34
Renal Insufficiency, Chronic8
Primary Myelofibrosis6
Hematologic Diseases5
Myelodysplastic Syndromes5
Bone Marrow Diseases4
Myeloproliferative Disorders4
Splenomegaly3
Hemoglobinuria, Paroxysmal2
Hemorrhagic Disorders2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.